Keywords: CDT; Catheter Directed Thrombolysis; CT; Computed tomography; CTA; CT angiography; DOAC; direct oral anticoagulant; DUS; Doppler ultrasound; DVT; deep vein thrombosis; ECMO; Extra Corporeal Membrane Oxygenation; ICH; intracranial hemorrhage; ICU; intensiv
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Amax; maximal thrombin concentration; APTT; activated partial thromboplastin time; AT; antithrombin III; CVerror; relative random error of measurement; CVii; inter-individual coefficient of variability; CVtotal; total coefficient of variation; ETP; endoge
Keywords: critically ill; heparin; heparin-induced thrombocytopenia; thrombocytopenia; thrombosis; APTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DOAC; direct oral anticoagulant; ECMO; extracorporeal membrane oxygenation;
Keywords: AIS; Abbreviated Injury Scale; DVT; deep venous thrombosis; ED; emergency department; HR; heart rate; IQR; interquartile range; ISS; Injury Severity Score; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; pRBC; packed RBC; SBP; systolic blood p
Keywords: early diagnosis of HIT; heparin; HIT; plasma exchange, plasmapheresis; thrombocytopenia; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; OD; optical density; PEA; PF4-dependent P-selectin expression assay; PF4; platelet fa
Keywords: DVT; Deep vein thrombosis; PE; pulmonary embolism; IPC; intermittent pneumatic compression; UFH; unfractionated heparin; TIA; Transient Ischemic Attack; LMWH; low molecular-weight heparin; VP-scan; ventilation perfusion scan; HIT; heparin-induced thromboc
Keywords: thrombosis; aspirin; platelet function; cardiac surgery; pediatrics; AA; arachidonic acid; ARU; aspirin reaction units; AUC; Area under the curve; CI; confidence interval; CLIA; Clinical Laboratory Improvement Amendments; IQR; interquartile range; TEG-PM;
Keywords: ACCP; American College of Chest Physicians; DOACS; Direct oral anticoagulants; HIT; heparin induced thrombocytopenia; LMWH; low molecular weight heparin; UFH; unfractionated heparin; VKA; vitamin K antagonists; Anticoagulation; Children; Pediatric; Hepari
Keywords: USDVT, unusual site deep vein thrombosis; VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; PVT, portal vein thrombosis; CVC, central venous catheter; JAK2, Janus kinase 2; CT, computed tomography; MR, magnetic resonance; UFH
Keywords: AF; atrial fibrillation; AUC; area under the curve; LMWH; low-molecular-weight heparin; mAVR; mechanical aortic valve replacement; OAT; oral anticoagulation therapy; OR; odds ratio; PTT; partial thromboplastin time; UFH; unfractionated heparin;
Keywords: antibiotic therapy; deep venous thrombosis; pulmonary embolism; BRS; bleeding risk score; EMR; electronic medical record; ICD-9; International Classification of Disease, Ninth Revision; IMPROVE; International Medical Prevention Registry on Venous Thromboe
Keywords: pulmonary embolism; deep vein thrombosis; lung cancer resection; screening; prevalence; CT; computed tomography; CTPA; computed tomography pulmonary angiogram; DVT; deep venous thrombosis; LMHW; Low-molecular-weight heparin; PE; pulmonary embolism; UFH; u
Keywords: UFH; unfractionated heparin; LMWH; low-molecular weight heparins; rFXa; recombinant factor Xa; HBC; heparin-binding copolymer; PEG; poly(ethylene glycol); PMAPTAC; poly(3-(methacryloylamino)propyl trimethylammonium chloride); MAPTAC; 3-(methacryloylami
Keywords: aPTT; Activated partial thromboplastin time; AT; Antithrombin; ATC; Antithrombin concentrate; TCH; Texas Children's Hospital; UFH; Unfractionated heparin;
Keywords: VTE; venous thromboembolism; LMWH; low molecular weight heparin; UFH; unfractioned heparin; VKA; vitamin k antagonists; RIETE; Registro Informatizado de Enfermedad TromboEmbólica; DVT; deep vein thrombosis; PE; pulmonary embolism; CUS; compressive ultras
Keywords: AUROC; area under the receiver operating curve; CABG; coronary artery bypass grafting; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; MCS; major cardiac surgery; NPV; negative predictiv
Keywords: UFH; unfractionated heparin; LMWH; low molecular weight heparin; APC; activated protein C; DVT; deep vein thrombosis; IU; international units; tPA; tissue plasminogen activator; Inhaled; Antithrombotic therapy; Thrombolytic therapy;
Keywords: PE; Pulmonary Embolism; VTE; Venous Thromboembolism; DVT; Deep-Vein Thrombosis; ACCP; American College of Chest Physicians; RIETE; Computerized Registry of Patients with Venous Thromboembolism; ESC; European Society of Cardiology; US; United States; UFH;
Keywords: CTPA; CT pulmonary angiography; DKA; diabetic ketoacidosis; ECMO; extracorporeal membrane oxygenation; LMWH; low-molecular-weight heparin; LV; left ventricle; MI; myocardial infarction; PE; pulmonary embolism; PRES; posterior reversible encephalopathy syn
Keywords: Bivalirudin; Heparin; Angina; Acute coronary syndrome; Non-ST-elevation myocardial infarction; ST-elevation myocardial infarction; ACS; acute coronary syndromes; STEMI; ST-segment elevation myocardial infarction; NSTEMI; non-ST-segment elevation myocardia
Keywords: Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: IV; intravenous; UFH; unfractionated heparin; LMWH; low-molecular-weight heparins; VTE; venous thromboembolism; ACS; acute coronary syndrome; CrCl; creatinine clearance; UCDMC; University of California, Davis Medical Center; ISTH; International Society on
Keywords: CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Keywords: CI; confidence interval; DVT; deep vein thrombosis; FDA; Food and Drug Administration; LMWH; low-molecular weight heparin; NOAC; New oral anticoagulant; PE; pulmonary embolism; RR; relative risk; UFH; unfractionated heparin; VKA; vitamin K antagonist; VTE
Keywords: AC; Anticoagulant; ALL; Acute lymphoblastic leukemia; CSF; Cerebrospinal fluid; GEE; Generalized estimating equations; LMWH; Low molecular weight heparin; LP; Lumbar puncture; RBC; Red blood cells; UFH; Unfractionated heparin;
Keywords: PCI; percutaneous coronary intervention; OAC; oral anticoagulation; AF; atrial fibrillation; INR; international normalized ratio; UFH; unfractionated heparin; ACT; activated clotting time; BARC; Bleeding Academic Research Consortium; TIMI; Thrombolysis in
Keywords: CVC; Central venous catheter; DVT; Deep venous thrombosis; ICU; Intensive care unit; PE; Pulmonary embolism; UFH; Unfractionated heparin;
Keywords: ICU; intensive care unit; PROTECT trial; The PROphylaxis for ThromboEmbolism in Critical Care Trial; UFH; unfractionated heparin; DVT; deep vein thrombosis; APACHE; Acute Physiology and Chronic Health Evaluation; Adjudication; Anticoagulation; Bleeding; C
Keywords: GAG; glycosaminoglycan; FG; fucosylated glycosaminoglycan; DFG; depolymerized fucosylated glycosaminoglycan; UFH; unfractionated heparin; LMWH; low-molecular-weight heparin; DD; deacetylation degree; GalNAc4S6S; 4,6-O-disulfated N-acetylgalactosamine; Glc
Keywords: AIS; Arterial ischemic stroke; ASA; Aspirin; BBB; Blood-brain barrier; CBF; Cerebral blood flow; CNS; Central nervous system; CT; Computed tomography; IAT; Intra-arterial thrombolysis; IVT; Intravenous thrombolysis; LMWH; Low molecular-weight heparin; MCA
Keywords: heparin; platelet-activating antibodies; thrombocytopenia; thrombosis; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; OD; optical density; PF4; platelet factor 4; SRA; serotonin-release
Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin
Keywords: LMWH; low molecular weight heparin; LMWL; low molecular weight lignin; PEG; polyethylene glycol; UFH; unfractionated heparin; Allosteric inhibition; Exosites; Heparin; Heparin mimetics; Thrombin;
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Keywords: 4T; Thrombocytopenia, Timing of platelet count fall, Thrombosis or other sequelae, other causes of Thrombocytopenia; Ab; antibody; ACT; activated clotting time; aPTT; activated partial thromboplastin time; AVR; aortic valve repair; CABG; coronary artery b
Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery
Keywords: anticoagulation; heparin; bleeding; thrombosis; congenital heart disease; Anti-Xa; anti-factor Xa activity; aPTT; activated partial thromboplastin time; ATIII; antithrombin III; CI; confidence interval; CICU; cardiac intensive care unit; IQR; interquartil
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes
Keywords: acute coronary syndrome; bivalirudin; GP IIb/IIIa inhibitor; heparin; MATRIX; ACS; acute coronary syndrome(s); CABG; coronary artery bypass grafting; GPI; glycoprotein IIb/IIIa inhibitor; MACE; major adverse cardiovascular event; NACE; net adverse clinica
Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non-Vitamin K Antagonist Oral Anticoagulants
Keywords: AF; atrial fibrillation; BID; twice daily; CKD; chronic kidney disease; CL/F; apparent total clearance after oral administration; CrCL; creatinine clearance; CYP3A4; cytochrome P450 3A4; DVT; deep vein thrombosis; eGFR; estimated glomerular filtration rat
The Evolving Face of Myocardial Reperfusion in Acute Coronary Syndromes: A Primer for the Internist
Keywords: ACS; acute coronary syndrome; ACT; activated clotting time; ADP; adenosine diphosphate; AHA/ACC; American Heart Association American/College of Cardiology; APTT; activated partial thromboplastin time; AVM; arteriovenous malformation; BID; twice daily; CAB
Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus
Keywords: APTT; activated partial thromboplastin time; C1-INH; C1 esterase inhibitor; DC; doubling concentration; dn/dc; refractive index increment; DS; degree of sulfation; F.v.-fuc; fucoidan extracted from Fucus vesiculosus; FXII; factor XII; IC50; half maximal i
Comparative Effectiveness of Enoxaparin vs Dalteparin for Thromboprophylaxis After Traumatic Injury
Keywords: comparative effectiveness; dalteparin; enoxaparin; prophylaxis; trauma; VTE; DID; difference-in-differences; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; PTSF; Pennsylvania Trauma System Foundation; RR; rate ratio; SDF; standardized differe
Synthesis of hybrid materials using graft copolymerization on non-cellulosic polysaccharides via homogenous ATRP
Keywords: AAP; 4-aminoantipyrine; AGET; activators generated by electron transfer; AGP; agarose palmitate; AGU; anhydroglucose unit; AMIMB; 1-allyl-3-methylimidazolium bromide; AS; acetylated starch; Au NPs; gold nanoparticles; BIBA; α-bromoisobutyric acid; BIBB;
Thrombocytopenia associated with TAVI-The summary of possible causes
Keywords: AS; aortic valve stenosis; BCMD; blood contacting medical devices; DAPT; dual antiplatelet therapy; DIC; disseminated intravascular coagulation; ES; Edwards Sapien; FS; Freedom Solo; F1+2; prothrombin fragments 1+2; GP; platelet glycoprotein; HIT; heparin
Implementation of a rapid HIT immunoassay at a university hospital - Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia
Keywords: CLIA; chemiluminescent immunoassay; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thrombocytopenia; ICU; intensive care unit
Effects of fucoidans and heparin on reactions of neutrophils induced by IL-8 and C5a
Keywords: Fucoidan (PubChem CID: 92023653); Sodium Heparin (PubChem CID: 22833565); AUC; area under the curve; BSA; bovine serum albumin; C5a; complement component C5a; DS; degree of sulfation; D.s.-SP; sulfated polysaccharides of Delesseria sanguinea; EC50; half m
Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves
Keywords: fetal risk; maternal risk; pregnancy; CI; confidence interval; LMWH; low-molecular-weight heparin; MHV; mechanical heart valve; RAR; ratio of averaged risk; UFH; unfractionated heparin; VKA; vitamin K antagonist;
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI
Keywords: average daily rate; bleeding events; ischemic events; percutaneous coronary intervention; ST-segment elevation myocardial infarction; ACS; acute coronary syndrome; ADBR; average daily bleeding rate; ADIR; average daily ischemic rate; ADR; average daily ra
Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: Two case reports providing evidence for the role of preoperative LMWH in triggering sensitization
Keywords: HIT; heparin-induced thrombocytopenia; UFH; unfractionated heparin; LMWH; low molecular weight heparin; ONCAB; on-pump coronary artery bypass; OPCAB; off-pump coronary artery bypass; CPB; cardiopulmonary bypass; AT; antithrombin; ACT; activated clotting t
Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement
Keywords: Interventional cardiology; Transcatheter aortic valve replacement; Non-access site bleeding; angio-MDCT; multidetector computed tomography angiography; TAVR; transcatheter aortic valve replacement; UFH; unfractionated heparin; VARC; Valve Academic Researc
Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors
Keywords: FG; fucosylated glycosaminoglycan; dFG; depolymerized fucosylated glycosaminoglycan; UFH; unfractionated heparin; LMWH; low molecular weight heparin; FXase; factor Xase; AT; antithrombin; FIIa; thrombin; FXa; factor Xa; FIXa; factor IXa; BLI; biolayer int
Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry
Keywords: ST-segment elevation myocardial infarction; Unfractionated heparin; Enoxaparin; Bivalirudin; Outcomes; Syndrome coronaire aigu avec élévation du segment ST; Héparine non fractionnée; Enoxaparine; Bivalirudine; Pronostic; ATOLL; Acute myocardial infarc
Inhibition of coagulation proteases Xa and IIa decreases ischemia-reperfusion injuries in a preclinical renal transplantation model
Keywords: α-SMA; α-smooth muscle actin; DCD; donors deceased after cardiac death; EMT; epithelial-mesenchymal transition; FBS; fetal bovine serum; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; HAEC; human aortic endothelial cell; HES; hematoxylin-eosin-s